Knowledge Graph

Graph explorer

Search resolved entities, walk their edges, and read the sentence behind every one.

Entities25 of 207,987

Entity

central nervous system disease treatment

market2 mentionslast seen Nov 2, 2026

Market for medicines treating CNS diseases including opioid use disorder, psychiatry, neurology, and related conditions.

Relationships 6

Supernus Pharmaceuticals, Inc.applies tocentral nervous system disease treatment93% confidence1 source
SUBLOCADEapplies tocentral nervous system disease treatment85% confidence1 source
Qelbreeapplies tocentral nervous system disease treatment85% confidence1 source
GOCOVRIapplies tocentral nervous system disease treatment85% confidence1 source
ONAPGOapplies tocentral nervous system disease treatment85% confidence1 source
ZURZUVAEapplies tocentral nervous system disease treatment85% confidence1 source

central nervous system disease treatment

Relationship

GOCOVRIapplies tocentral nervous system disease treatment

85% confidence1 supporting mentions

Either name opens that entity’s relationships.

Sources 1

filingSEC EDGARNov 2, 2026Indivior Pharmaceuticals, Inc. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 2.01: Completion of Acquisition or Disposition of Assets; Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Item 7.01: Regulation FD Disclosure; Item 9.01: Financial Statements and Exhibits
An 11-product portfolio spans opioid use disorder, psychiatry, and neurology